viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 4723
tüüp :
ajaleht
interneti link :
;80,1:53-58
uurimisrühmad :
Tokyo - Nippon Medical School Hospital, Department of Pharmacy
Autor :
Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H
pealkiri :
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
publikatsioon :
Am J Health-Syst Pharm https://doi.org/10.1093/a 2022
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Dexmedetomidine
4 µg/ml
+
Remimazolam
5 mg/ml
+
Fentanyl citrate
50 µg/ml
+
Remimazolam
5 mg/ml
+
Midazolam hydrochloride
5 mg/ml
+
Remimazolam
5 mg/ml
+
Remifentanil hydrochloride
100 µg/ml
+
Remimazolam
5 mg/ml
+
Remimazolam
5 mg/ml
+
Dexmedetomidine
4 µg/ml
+
5 mg/ml
+
Fentanyl citrate
50 µg/ml
+
5 mg/ml
+
Midazolam hydrochloride
5 mg/ml
+
5 mg/ml
+
Remifentanil hydrochloride
100 µg/ml
+
5 mg/ml
+
Rocuronium bromide
10 mg/ml
+
5 mg/ml
+
Vecuronium bromide
1 mg/ml
+
Rocuronium bromide
10 mg/ml
+
Remimazolam
5 mg/ml
+
Vecuronium bromide
1 mg/ml
+
Remimazolam
5 mg/ml
+
Mentions Légales
